Your browser doesn't support javascript.
loading
Anti-inflammatory effects of ozenoxacin, a topical quinolone antimicrobial agent.
Tabara, Keisuke; Tamura, Rie; Nakamura, Aki; Mori, Sachi; Kitano, Takamichi; Fujikawa, Koki; Fujikawa, Mika; Okamoto, Kazuaki; Kanayama, Shoji; Uratsuji, Hideya; Ikeda, Fumiaki; Matsumoto, Tatsumi.
Afiliación
  • Tabara K; Maruho Co., Ltd, Kyoto R&D Center, Drug Development Laboratories, Kyoto Research Park, Bldg. #5, 93 Chudoji Awata-cho, Shimogyo-ku, Kyoto, 600-8815, Japan. tabara_dpk@mii.maruho.co.jp.
  • Tamura R; Maruho Co., Ltd, Kyoto R&D Center, Drug Development Laboratories, Kyoto Research Park, Bldg. #5, 93 Chudoji Awata-cho, Shimogyo-ku, Kyoto, 600-8815, Japan.
  • Nakamura A; Maruho Co., Ltd, Kyoto R&D Center, Drug Development Laboratories, Kyoto Research Park, Bldg. #5, 93 Chudoji Awata-cho, Shimogyo-ku, Kyoto, 600-8815, Japan.
  • Mori S; Maruho Co., Ltd, Kyoto R&D Center, Drug Development Laboratories, Kyoto Research Park, Bldg. #5, 93 Chudoji Awata-cho, Shimogyo-ku, Kyoto, 600-8815, Japan.
  • Kitano T; Maruho Co., Ltd, Kyoto R&D Center, Drug Development Laboratories, Kyoto Research Park, Bldg. #5, 93 Chudoji Awata-cho, Shimogyo-ku, Kyoto, 600-8815, Japan.
  • Fujikawa K; Maruho Co., Ltd, Kyoto R&D Center, Drug Development Laboratories, Kyoto Research Park, Bldg. #5, 93 Chudoji Awata-cho, Shimogyo-ku, Kyoto, 600-8815, Japan.
  • Fujikawa M; Maruho Co., Ltd, Kyoto R&D Center, Drug Development Laboratories, Kyoto Research Park, Bldg. #5, 93 Chudoji Awata-cho, Shimogyo-ku, Kyoto, 600-8815, Japan.
  • Okamoto K; Maruho Co., Ltd, Kyoto R&D Center, Drug Development Laboratories, Kyoto Research Park, Bldg. #5, 93 Chudoji Awata-cho, Shimogyo-ku, Kyoto, 600-8815, Japan.
  • Kanayama S; Maruho Co., Ltd, Kyoto R&D Center, Drug Development Laboratories, Kyoto Research Park, Bldg. #5, 93 Chudoji Awata-cho, Shimogyo-ku, Kyoto, 600-8815, Japan.
  • Uratsuji H; Maruho Co., Ltd, Kyoto R&D Center, Drug Development Laboratories, Kyoto Research Park, Bldg. #5, 93 Chudoji Awata-cho, Shimogyo-ku, Kyoto, 600-8815, Japan.
  • Ikeda F; Maruho Co., Ltd, Kyoto R&D Center, Drug Development Laboratories, Kyoto Research Park, Bldg. #5, 93 Chudoji Awata-cho, Shimogyo-ku, Kyoto, 600-8815, Japan.
  • Matsumoto T; Maruho Co., Ltd, Kyoto R&D Center, Drug Development Laboratories, Kyoto Research Park, Bldg. #5, 93 Chudoji Awata-cho, Shimogyo-ku, Kyoto, 600-8815, Japan.
J Antibiot (Tokyo) ; 73(4): 247-254, 2020 04.
Article en En | MEDLINE | ID: mdl-31974519
ABSTRACT
Ozenoxacin is a topical quinolone showing potent antimicrobial activities against Gram-negative and Gram-positive bacteria and is widely used for the treatment of inflammatory acne. However, the anti-inflammatory activities of ozenoxacin have not been examined so far. In the present study, we investigated the in vitro and in vivo anti-inflammatory effects of ozenoxacin. The production of interleukin (IL)-6 and IL-8 by human epidermal keratinocytes stimulated by heat-killed Cutibacterium acnes was significantly inhibited by ozenoxacin at concentrations from 1 to 30 µg ml-1. Likewise, the production of IL-6, IL-8, and tumor necrosis factor alpha by stimulated THP-1 cells, a human monocyte cell line, was inhibited by ozenoxacin at concentrations from 1 to 30 µg ml-1. The production of IL-1ß by THP-1 was also inhibited by ozenoxacin at the concentration of 30 µg ml-1. Phosphorylation of the mitogen-activated protein kinases and degradation of IκB-α, an inhibitory factor of NF-κB in keratinocytes and THP-1 cells, was increased by stimulation with heat-killed C. acnes. Of these activated intracellular pathways, the p38 phosphorylation pathway was remarkably reduced by ozenoxacin in both keratinocytes and THP-1 cells. In addition, the application of 2% ozenoxacin suppressed the increase in the ear thickness of rats induced by an intracutaneous injection of heat-killed C. acnes. These findings suggest that ozenoxacin possesses an anti-inflammatory activity, which may contribute to its therapeutic effects on inflammatory acne.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quinolonas / Aminopiridinas / Inflamación / Antiinflamatorios Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: J Antibiot (Tokyo) Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quinolonas / Aminopiridinas / Inflamación / Antiinflamatorios Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: J Antibiot (Tokyo) Año: 2020 Tipo del documento: Article País de afiliación: Japón